Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Parsons, Dolly Penn, Qian Li, R. Cress, B. Pollock, M. Malogolowkin, T. Wun, T. Keegan (2018)
Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012–2013 in the United StatesPediatric Blood & Cancer, 66
S. Ansell, A. Lesokhin, I. Borrello, A. Halwani, E. Scott, M. Gutierrez, S. Schuster, M. Millenson, D. Cattry, G. Freeman, S. Rodig, B. Chapuy, A. Ligon, Lili Zhu, J. Grosso, S. Kim, J. Timmerman, M. Shipp, P. Armand (2015)
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.The New England journal of medicine, 372 4
T. Waters, Cyril Chang, W. Cecil, Panagiotis Kasteridis, D. Mirvis (2011)
Impact of high-deductible health plans on health care utilization and costs.Health services research, 46 1 Pt 1
John Freedman, Linda Green, B. Landon (2016)
All-Payer Claims Databases - Uses and Expanded Prospects after Gobeille.The New England journal of medicine, 375 23
J. Connors, W. Jurczak, D. Straus, S. Ansell, W. Kim, A. Gallamini, A. Younes, S. Alekseev, Á. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. Savage, N. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P. Zinzani, D. Cunningham, A. Rosta, N. Josephson, E. Song, J. Sachs, R. Liu, H. Jolin, D. Huebner, J. Radford (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.The New England journal of medicine, 378 9
update on diagnosis , risk - strati fi cation , and management
Sally Adams, P. Newacheck, M. Park, C. Brindis, C. Irwin (2007)
Health Insurance Across Vulnerable Ages: Patterns and Disparities From Adolescence to the Early 30sPediatrics, 119
Center for Health Information and Analysis: Agreement for Use of Center for Health Information and Analysis (CHIA) Data Containing Protected Health Information
A. Younes, A. Gopal, Scott Smith, S. Ansell, J. Rosenblatt, K. Savage, R. Ramchandren, N. Bartlett, B. Cheson, S. Vos, A. Forero-Torres, C. Moskowitz, J. Connors, A. Engert, E. Larsen, D. Kennedy, E. Sievers, Robert Chen (2012)
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 18
S. Parsons, Anita Kumar (2018)
Adolescent and young adult cancer care: Financial hardship and continued uncertaintyPediatric Blood & Cancer, 66
Anju Nair (2020)
Hodgkin lymphomaNature Reviews Disease Primers, 6
(2016)
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: A multicentre, multicohort, single-arm phase 2 trial
Nobuhiro Ooba, S. Setoguchi, T. Ando, Tsugumichi Sato, Takuhiro Yamaguchi, M. Mochizuki, K. Kubota (2013)
Claims-Based Definition of Death in Japanese Claims Database: Validity and ImplicationsPLoS ONE, 8
V. Murthy, H. Krumholz, C. Gross (2004)
Participation in cancer clinical trials: race-, sex-, and age-based disparities.JAMA, 291 22
M. Dworsky (2017)
Using All-Payer Claims Databases to Study Insurance and Health Care Utilization DynamicsJournal of General Internal Medicine, 32
S. Rosenbaum (2015)
Addressing Medicaid/marketplace churn through multimarket plans: assessing the current state of play.Journal of health politics, policy and law, 40 1
N. Schmitz, B. Pfistner, M. Sextro, M. Sieber, A. Carella, M. Haenel, F. Boissevain, R. Zschaber, P. Müller, H. Kirchner, A. Lohri, S. Decker, Bettina Koch, D. Hasenclever, A. Goldstone, V. Diehl (2002)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialThe Lancet, 359
Elizabeth Ward, M. Halpern, N. Schrag, V. Cokkinides, C. DeSantis, Priti Bandi, R. Siegel, A. Stewart, A. Jemal (2008)
Association of Insurance with Cancer Care Utilization and OutcomesCA: A Cancer Journal for Clinicians, 58
PURPOSEAlthough hematologic malignancies affect adults of all ages, few data exist on the real-world patterns of care for patients younger than 65 years in the United States. Understanding patterns of care from diagnosis through relapsed disease may provide insight about care across community and academic centers. We used a large statewide claims database to describe the path of Hodgkin lymphoma (HL) treatment among adults age < 65 years at diagnosis.METHODSWe defined a cohort of commercially insured patients with HL who underwent hematopoietic stem-cell transplantation (HSCT) from 2009 to 2013 in the Massachusetts All-Payer Claims Database (APCD). The primary goals of our study were to accurately identify patients and their treatment patterns who had relapsed/refractory HL and underwent HSCT. We also characterized time to treatment failure and overall survival.RESULTSA total of 7,613 patients had International Classification of Diseases, Ninth Revision, diagnostic codes for HL. From our algorithm, we identified 117 patients as part of the final cohort who underwent autologous and/or allogeneic HSCT. Median age was 39.0 years and 50.4% were female. Initial therapy was identified for 68 of the 117 patients (58.1%). Most (> 74.4%) of the identified transplants were autologous, and 19 patients (16.2%) underwent allogeneic transplant, with or without prior autologous transplant. Of the 68 patients with initial therapy data, the median time to HSCT after completion of initial treatment was 223.5 days (Q1 = 151.5, Q3 = 414.5).CONCLUSIONWe used the Massachusetts APCD to create a cohort of patients age < 65 years with relapsed/refractory HL. Our findings support the use of APCD for the large-scale analysis of patient characteristics, treatment patterns, and outcomes for young adult patients with hematologic malignancies.
JCO: Clinical Cancer Informatics – Wolters Kluwer Health
Published: May 18, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.